Institutional Ownership
Actuate Therapeutics Inc
CUSIP 005083100COMACTUQ1 2026
13D / 13G Filings
4
Schedule 13D/13G on record
Beneficial Filers
3
Distinct reporting persons
Largest Stake
52.4%
Max % of class reported
Institutional Holders
57
13F filers (latest quarter)
Beneficial Owners — Schedule 13D / 13G
4 filings · latest Dec 17, 2025
Top Institutional Holders (13F)
Largest reported positions · latest quarter
| # | Fund | Shares | Value |
|---|---|---|---|
| 1 | Bios Capital Management, LP | 10.05M | $27.54M |
| 2 | Voss Capital, LP | 1.73M | $4.73M |
| 3 | Blackrock, Inc. | 427.2K | $1.17M |
| 4 | Geode Capital Management, LLC | 228.3K | $625.6K |
| 5 | Connective Capital Management, LLC | 113.3K | $310.3K |
| 6 | Palogic Value Management, L.P. | 100.0K | $274.0K |
| 7 | Northern Trust Corp | 97.9K | $268.1K |
| 8 | Texas Capital Bank Wealth Management Services Inc | 94.6K | $259.2K |
| 9 | State Street Corp | 66.0K | $180.9K |
| 10 | Abs Direct Equity Fund LLC | 50.0K | $137.0K |